This session takes a closer look at one of the key challenges associated with integrated evidence generation planning that was identified in our first installment. Experts share insights and practical advice on ways to identify and overcome barriers to aligning multiple functions in the development and implementation of integrated evidence generation plans to minimize risk and optimize value, accounting for medical affairs, patient, regulatory and commercial perspectives.
